549Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product on Duchenne muscular
dystrophy locus. Cell. 1987;51:919–28.
Jacob HJ. Next-generation sequencing for clinical diagnostics. N Engl J Med. 2013;369:1557–8.
Jain KK. Biomarkers: technologies, markets and companies. Basel: Jain PharmaBiotech; 2015a.
Jain KK. Cytogenetics: technologies, markets and companies. Basel: Jain PharmaBiotech; 2015b.
Jain KK. DNA sequencing: technologies, markets and companies. Basel: Jain PharmaBiotech;
2015c.
Jain KK. Molecular diagnostics: technologies, markets and companies. Basel: Jain PharmaBiotech;
2015d.
Johansen CT, Wang J, Lanktree MB, et al. Excess of rare variants in genes identifi ed by genome-
wide association study of hypertriglyceridemia. Nat Genet. 2010;42:684–7.
Jordan CT, Cao L, Roberson ED, et al. PSORS2 is due to mutations in CARD14. Am J Hum
Genet. 2012;90:784–95.
Malik V, Rodino-Klapac LR, Mendell JR. Emerging drugs for Duchenne muscular dystrophy.
Expert Opin Emerg Drugs. 2012;17:261–77.
Nakamura A, Takeda S. Exon-skipping therapy for Duchenne muscular dystrophy. Neuropathology.
2009;29:494–501.
Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifi es the cause of a mendelian dis-
order. Nat Genet. 2009;42:30–5.
Roach JC, Glusman G, Smit AF, et al. Analysis of genetic inheritance in a family quartet by
whole- genome sequencing. Science. 2010;328:636–9.
Saunders CJ, Miller NA, Soden SE. Rapid whole-genome sequencing for genetic disease diagnosis
in neonatal intensive care units. Sci Transl Med. 2012;4:154ra135.
Tolar J, Park IH, Xia L, et al. Hematopoietic differentiation of induced pluripotent stem cells from
patients with mucopolysaccharidosis type I (Hurler syndrome). Blood. 2011;117:839–47.
van Deutekom JC, de Kimpe SJ, Campion GV. Antisense oligonucleotides as personalized medi-
cine for Duchenne muscular dystrophy. Drug Discov Today Ther Strateg. 2013. doi: 10.1016/j.
ddstr.2013.04.001.
Wang K, Dickson SP, Stolle CA, et al. Interpretation of association signals and identifi cation of
causal variants from genome-wide association studies. Am J Hum Genet. 2010;86:730–42.
Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of
mendelian disorders. N Engl J Med. 2013;369:1502–11.
Yokota T, Lu QL, Partridge T. Effi cacy of systemic morpholino exon-skipping in Duchenne
dystrophy dogs. Ann Neurol. 2009;65:667–76.
References